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Dengue infection is a major public health prob-
lem in tropical areas, predominantly in chil-
dren. The mosquito-borne disease is caused by 
four related serotypes of the dengue virus (DV), 
a fl  avivirus like West Nile and yellow fever 
  virus. A wide range of disease severities is ob-
served; 100 million cases each year have dengue 
fever, an acute febrile illness. Half a million 
patients suff  er from the more severe dengue 
haemorrhagic fever (DHF) with plasma leakage, 
thrombocytopenia, and occasionally hypovole-
mic shock (1). If untreated, the mortality rate 
of DHF is around 30% but can be reduced to 
0.2–5% by fl  uid replacement. To date, no vac-
cines or antiviral therapies are available.
The pathogenesis of severe dengue disease is 
incompletely understood. Epidemiological stud-
ies show an increased risk of severe DHF in a 
secondary infection with a heterologous sero-
type. Preexisting nonneutralizing antibodies 
are thought to form immunocomplexes with 
the virus, thereby enhancing the infection of 
Fcγ receptor–bearing cells like monocytes/
macrophages (antibody-dependent enhance-
ment; references 2, 3). However, it is still un-
clear how this can lead to plasma leakage as the 
major symptom of DHF. Excessive activation 
of the innate and adaptive immune system, es-
pecially of cross-reactive memory T cells, ap-
pears to augment the secretion of vasoactive 
factors like TNF-α, IFN-γ, IL-2, and IL-6 (4–6). 
Indeed, increased numbers of activated CD8+ 
T cells and levels of cytokines have been reported 
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Dengue virus infection is an increasingly important tropical disease, causing 100 million 
cases each year. Symptoms range from mild febrile illness to severe hemorrhagic fever. The 
pathogenesis is incompletely understood, but immunopathology is thought to play a part, 
with antibody-dependent enhancement and massive immune activation of T cells and 
monocytes/macrophages leading to a disproportionate production of proinfl  ammatory 
cytokines. We sought to investigate whether a defective population of regulatory T cells 
(T reg cells) could be contributing to immunopathology in severe dengue disease.
CD4+CD25highFoxP3+ T reg cells of patients with acute dengue infection of different 
severities showed a conventional phenotype. Unexpectedly, their capacity to suppress T cell 
proliferation and to secrete interleukin-10 was not altered. Moreover, T reg cells sup-
pressed the production of vasoactive cytokines after dengue-specifi  c stimulation. Further-
more, T reg cell frequencies and also T reg cell/effector T cell ratios were increased in 
patients with acute infection. A strong indication that a relative rise of T reg cell/effector 
T cell ratios is benefi  cial for disease outcome comes from patients with mild disease in which 
this ratio is signifi  cantly increased (P < 0.0001) in contrast to severe cases (P = 0.2145). 
We conclude that although T reg cells expand and function normally in acute dengue 
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in DHF (7, 8). Thus, the pathogenesis of dengue infection is 
likely to be a result of the immune response rather than of the 
virus itself.
CD4+ regulatory T cells (T reg cells) have been described 
to play a key role in the control of the immune system. The 
most commonly used marker is CD25 (IL-2Rα; reference 9), 
although the recently identifi  ed transcription factor FoxP3 is 
more specifi  c (10). Suppression is mediated via direct cell–cell 
contact or via the secretion of IL-10 or TGF-β (11).
T reg cells play a role not only in autoimmunity, trans-
plantation, and cancer but also in infections (12, 13). They 
can limit immunopathology, which was shown for mouse 
Helicobacter hepaticus and herpes infections, for example (14, 15). 
So far, they have only been described in chronic viral infections. 
This study is the fi  rst to report on a functional T reg cell 
population in a nonpersistent viral infection.
As immunopathology is thought to play a major role in 
the pathogenesis of severe dengue disease, we hypothesized 
that the T reg cell response in acute infection may be inade-
quate to control immune activation. However, we found that 
T reg cells are fully functional and expand in acute dengue 
infection. Moreover, they were able to suppress the produc-
tion of vasoactive cytokines such as IFN-γ, TNF-α, and IL-6 
in response to dengue antigens. Nevertheless, this expansion 
might be insuffi   cient to control the immune response in 
patients with severe disease. Strong support for this hypothesis 
comes from our observation that the relative expansion of 
T reg cell/eff  ector T cell ratios is only signifi  cant in children 
with mild disease in contrast to severe cases (P < 0.0001 and 
P = 0.2145, respectively).
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Characteristics of study cohort
89 serologically confi  rmed dengue patients were enrolled and 
grouped based on their disease severity (Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20061381/DC1). 
The acute phase of dengue infection was compared with a 
recovered time point. Age-matched healthy, uninfected con-
trols were compared with the recovered samples (adults only) 
and showed no diff  erence.
Identifi  cation of CD4+CD25high T reg cells
Patients’ blood cells were stained ex vivo for CD4, 8, and 25. 
CD4+ and CD8+ cells were gated in forward/sideward scat-
ter plots (Fig. 1 A). CD4+ monocytes were excluded (Fig. 1 B). 
Human CD25high T reg cells are not a distinct population 
and, therefore, are diffi   cult to gate in a reproducible way. We 
observed that CD4+ T cells with the highest expression of 
CD25, which are believed to be T reg cells, show a slight re-
duction of CD4 expression (bend of CD4 level). As this was 
a consistent fi  nding, we gated this population of cells in all 
samples to describe CD4+CD25high T reg cells (Fig. 1 C).
FoxP3 staining of CD4+CD25high T cells
As naive T cells express CD25 upon activation, the CD25high 
cell population of acutely infected dengue patients might con-
tain activated T cells beside T reg cells. The best marker for dis-
tinction is FoxP3 (10). To control our CD25-based gating, we 
stained frozen PBMCs of acutely infected and recovered sub-
jects for FoxP3 (Fig. 1 D) or used the corresponding isotype 
control (not depicted) and analyzed the percentage of FoxP3+ 
Figure 1.  Identifi  cation of CD25high T reg cells. Blood cells were 
stained ex vivo for CD4 and CD25. (A and B) Lymphocytes were gated (A), 
and monocytes were excluded (B). (C) CD25high cells with a slightly de-
creased CD4 expression were gated as T reg cells. (D–G) Frozen PBMCs of 
acutely infected and recovered subjects were stained for CD4, CD25, and 
FoxP3 (D), and FoxP3 levels of CD25neg, CD25int, and CD25high cells were 
analyzed (E–G). FoxP3+ cells show decreased CD4 levels. (H) The percent-
age of FoxP3+ cells in the CD25high population is identical at acute and 
recovered states. Error bars represent SEM. Applied gates are depicted as 
pink lines.JEM VOL. 204, May 14, 2007  981
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cells in the CD4+CD25negative (CD25neg), CD4+CD25intermediate 
(CD25int), and CD25high gate (Fig. 1, E–G). If activated CD25+/
FoxP3− T cells fell into the CD25high T reg cell gate, we would 
expect a drop of the percentage of FoxP3+ cells in acute disease 
in this gate. However, the percentage of FoxP3+ cells was com-
parable in acutely infected and recovered subjects (Fig. 1 H). 
Thus, we confi  rmed that even in acute dengue infection, the 
gated CD4+CD25high T cells are indeed T reg cells and not ac-
tivated CD25+ T cells. Therefore, the terms CD25high cells and 
T reg cells will be used synonymously throughout the study.
In addition, FoxP3 analysis confi  rmed our observation that 
the CD25high cells with less CD4 on their surface are human 
FoxP3+ T reg cells (Fig. 1, E–G). This reduction of CD4 ex-
pression has already been observed on mouse T reg cells 
(16, 17). Based on this, we suggest that a reduced CD4 expres-
sion could be used collaterally for the identifi  cation of T reg 
cells in cases in which FoxP3 cannot be applied as a marker.
T reg cells in dengue infection show 
the conventional phenotype
To describe the phenotype of T reg cells in acute dengue in-
fection, fresh blood cells of acutely infected patients with dif-
ferent severities of recovered as well as uninfected donors were 
stained ex vivo and analyzed using fl  ow cytometry. Expression 
of the memory marker CD45RO, death receptor CD95, early 
activation marker CD69, homing receptor CD62L, and in-
hibitory receptor CTLA-4 was addressed (Fig. 2, A–E). T reg 
cells of uninfected donors and recovered study participants 
showed the same phenotype (not depicted).
At recovery, the highest percentage of CD45RO+, 
CD95+, CD62L+, or CTLA-4+ cells was detected in the 
T reg cell population. CD69 was not expressed. This is in 
agreement with what has been described previously in healthy 
donors (18, 19). Interestingly, the expression level of all of 
these markers was unchanged on T reg cells in acute dengue 
infection. Signs of activation were only detectable in the 
CD25int gate, where, for example, CD69 and CTLA-4 ex-
pression was increased.
Collectively, the phenotype of T reg cells in acute den-
gue infection did not diff  er from that seen after recovery. 
This was the same for all of the diff  erent categories of disease 
severity. As in healthy donors, T reg cells were CD45ROhigh, 
CD95high, CD69−, CD62Lhigh, and CTLA-4high. In addition, 
we observed that acutely activated T cells could be found in 
the CD25int and not in the CD25high gate. Based on those re-
sults together with FoxP3 analysis, we suggest that in acute 
dengue infection, activated T cells express lower levels of 
CD25 than T reg cells and can clearly be distinguished.
T reg cells suppress the proliferation of CD4+ T cells 
in acute dengue infection
We determined the functionality of T reg cells in acute den-
gue infection by measuring their capacity to suppress the pro-
liferation of CD4+CD25− responder T cells in vitro. Because 
Figure 2.  T reg cells in dengue infection show conventional pheno-
types. (A–E) Blood cells of acutely infected (n = 8) and recovered (n = 11) 
subjects were stained ex vivo for CD4, 25, 45RO (A), 95 (B), 69 (C), 62L 
(D), or CTLA-4 (E). CD25neg, CD25int, and CD25high cells were compared 
(as   indicated). Representative histograms of individual patients are 
shown, and numbers indicate relevant percentages of positive cells.982  REGULATORY T CELLS IN ACUTE DENGUE INFECTION | Lühn et al. 
of the amounts of cells needed for the assay, we were re-
stricted to samples of dengue-infected adults. CD4+CD25+ 
and CD4+CD25− T cells were separated from acutely in-
fected, recovered, and uninfected subjects. The responder 
T cells were CFSE labeled and incubated with the same 
number or without T reg cells on plate-bound anti-CD3 and 
  allogeneic APCs. After 5 d in culture, cells were analyzed by 
fl   ow cytometry. As a negative control, cells were cultured 
without anti-CD3 (proliferation of <10%; not depicted). 
Analysis of the proliferation is shown for one acute sample in 
Fig. 3 A. Lymphocytes, including blasts, were gated and ana-
lyzed for their CFSE content. No diff  erence was detectable 
between recovered study participants and uninfected donors 
(not depicted). The proliferative capacity of CD4+CD25− 
T cells in acute dengue infection is comparable with that at 
convalescence: >55% of the cells proliferated (Fig. 3 B). Pro-
liferation was reduced drastically upon the addition of T reg 
cells. The level of suppression was >85% in acute and recov-
ered patients (Fig. 3 C). Reduction of the T reg cell/responder 
T cell ratio to 1:2 did not infl  uence the level of suppression 
(not depicted). Based on these results, we conclude that T reg 
cells are fully functional in acute dengue infection (i.e., their 
suppressive capacity is not altered). We suggest that the im-
munopathology in dengue disease is not caused by defective 
T reg cell function.
Culture supernatants were collected from the suppression 
assays on days 1 and 5, and the IL-10 content was analyzed. Only 
cultures with T reg cells were substantially positive for IL-10 
(Fig. 3 D). The amount of IL-10 produced was comparable in 
cells of both acutely infected and recovered subjects. Although 
IL-10 might serve as a possible mean of suppression, determina-
tion of the regulatory mechanisms needs further investigation.
T reg cells suppress the production of vasoactive cytokines 
after dengue-specifi  c stimulation
The eff  ect of T reg cells on the dengue-specifi  c production 
of vasoactive cytokines was determined by IFN-γ ELISPOT. 
PBMCs, CD25-depleted PBMCs (CD25− responder T cells), 
and T reg cells of 28 acute adult dengue patients were acti-
vated with DV-4 peptides plus inactivated virus (DV-2; 
Fig. 4 A). Stimulation of PBMCs without any, with irrele-
vant antigen, or of PBMCs of noninfected donors with den-
gue antigen (not depicted) did not result in any notable 
IFN-γ response. Strikingly, the IFN-γ production of dengue 
patients’ CD25 responder T cells (CD25−, 1,402 ± 635 
spot-forming units/106 cells) was signifi  cantly decreased (by 
around 50%) in the presence of T reg cells (CD25+, T reg 
cell/responder T cells ≈ 1/10; P = 0.0005). In addition, 
even the mere depletion of T reg cells from PBMCs led 
to a signifi  cant increase of IFN-γ release by nearly 20% 
(P = 0.0186). This suggests that T reg cells are eff  ective in 
suppressing cytokine production after dengue-specifi  c stimu-
lation at cell ratios found physiologically in the blood without 
the need for in vitro enrichment procedures.
To determine the eff  ect of T reg cells on the production 
of other cytokines, cells of some ELISPOT assays were cul-
tured for another 48 h (Fig. 4 B). Without stimulation, no 
notable amounts of cytokine were detected. A signifi  cant re-
duction of TNF-α (P = 0.0386) by 44% was detectable in 
the presence of enriched T reg cells.
To analyze the eff  ect of T reg cells on other blood cells, 
monocytes, CD25−, and T reg cells were isolated from three 
Figure 3.  Suppressive capacity of T reg cells is unaltered in acute 
dengue infection. (A–D) CD4+ cells were negatively sorted from acutely 
infected (n = 7) and recovered (n = 3) subjects and split into CD25+ 
and CD25− cells. CFSE-labeled CD25− cells were incubated with or with-
out CD25+ cells on plate-bound anti-CD3 and allogeneic APCs. After 
5 d, proliferation was analyzed in FACS analysis. (A) A representative 
CFSE staining of an acutely infected patient. (B) The percentage of prolif-
erating cells was comparable in acutely infected and recovered patients 
and decreased in the presence of CD25+ cells. (C) The suppressive capac-
ity of the T reg cells in acute infection was like after recovery. (D) At the 
acute and recovered states, IL-10 was detected on days 1 and 5 in 
supernatants of cultures with CD25+ cells. Means and SEM (error bars) 
are shown.JEM VOL. 204, May 14, 2007  983
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acute adult patients. The monocytes were cocultured at a 1:1 
ratio with CD25− cells or T reg cells and DV-4 peptides for T 
cell stimulation. After 40 h, monocytes were separated again 
and activated with antibody-coated inactivated DV-2 for 48 h. 
Subsequently, IL-6 levels were analyzed. Although the results 
were not signifi  cant, a trend was observed for a decrease of IL-6 
production (by 66%; P = 0.0779) by monocytes that were 
precultured with T reg cells instead of CD25− cells (Fig. 4 C).
From these data, we conclude that T reg cells that can 
suppress antigen-specifi  c responses to dengue can be detected 
in the blood of acutely infected patients. As demonstrated in 
vitro, they have an impact on the expression of IFN-γ, TNF-α, 
and IL-6 produced by T cells and monocytes in response to 
dengue antigens. This is of major importance, as all of these 
cytokines have been linked to plasma leakage and, thus, to 
the severity of dengue disease (4).
T reg cell frequencies and T reg cell/effector T cell ratios are 
increased in acute dengue infection, especially in mild cases
The frequency of CD4+CD25high T reg cells was determined 
in FACS analysis by staining patients’ fresh blood cells ex vivo. 
The acute samples were collected on days 4–13 of illness. T 
reg cells were gated, and frequencies were analyzed as a per-
centage of CD4+ cells. Absolute CD4 counts were   comparable 
in severe and mild cases. In adult patients, the frequency of 
T reg cells at the recovered state was comparable with those 
of healthy controls (2.71 ± 0.88% and 2.37 ± 0.55%, respec-
tively; not depicted). In acute infection, the T reg cell fre-
quency was slightly increased by 32% to 3.59 ± 1.47%, 
although it is not statistically signifi  cant (Fig. 5 A, I). A diff  er-
ence of 29% was detectable in children with severe disease 
(recovered, 3.12 ± 1.03% vs. acute, 4.01 ± 1.3%; Fig. 5 A, II). 
With P = 0.0531, this increase was close to signifi  cance. 
However, in contrast to this, the T reg cell frequency of chil-
dren with mild disease increased substantially by 61% from 
2.8 ± 0.97 to 4.52 ± 1.79% (Fig. 5 A, III). This diff  erence 
was highly statistically signifi  cant (P = 0.0006; comparable 
n values for severe- and mild-diseased children). Fig. 5 A (IV) 
summarizes the results for all three study groups.
More important than the sole increase of T reg cells for 
the outcome of a disease is the ratio between T reg cells and 
eff  ector T cells. We determined the percentage of all CD25+ 
cells as a measure for eff  ector T cells and calculated the T reg 
cell/eff  ector T cell ratios. In both severely sick adults and chil-
dren, the ratios changed in acute infection by 25% and 18%, 
respectively (Fig. 5 B, I and II). These diff  erences were not 
statistically signifi  cant. However, in children with mild disease, 
the ratios increased highly signifi  cantly by 88% at the acute 
state (P < 0.0001; Fig. 5 B, III). This increase was also noted 
to a lower extent (38%; P = 0.0192) in a small group of sam-
ples collected at an early state of mild acute disease (days 1–3 
of illness; not depicted). Fig. 5 B (IV) summarizes the devel-
opment of the ratios for the diff  erent groups of patients.
In summary, the T reg cell population that expands in 
acute dengue infection has the conventional phenotype and 
suppressive capacity. Our demonstration that T reg cells sup-
press the dengue-specifi  c secretion of vasoactive cytokines of 
eff  ector T cells leads us to suggest that this population plays 
an active role in dengue infection. Numbers and also T reg 
cell/eff  ector T cell ratios are increased. Despite this expan-
sion of functionally intact T reg cells, patients with severe 
disease still develop strong immunopathology and symptoms 
that require hospital admission. We propose that in severe 
disease, the expansion of this T reg cell population is insuffi   -
cient to control the immune response. This hypothesis is sup-
ported by our observation that T reg cell/eff  ector T cell ratios 
are only signifi  cantly increased in children with mild and not 
with severe disease (P < 0.0001 and P = 0.2145, respectively; 
Fig. 5 B, II–IV). A change in T reg cell/eff  ector T cell ratios 
could have a direct eff  ect on the disease severity, as we dem-
onstrated that T reg cells in the blood control the eff  ector 
T cell production of vasoactive cytokines, which is directly 
linked to plasma leakage and disease outcome.
An alternative explanation for the relative defi  ciency of T 
reg cells in the blood of severely sick patients could be diff  er-
ential migration of these cells to the tissues. It has been dem-
onstrated in HIV and hepatitis C virus infection that T reg 
cells can be detected at sites of preferential virus replication 
such as the lymphoid tissue or liver (20, 21). Although our 
data could be compatible with the increased migration of 
Figure 4.  T reg cells suppress dengue-specifi  c vasoactive cytokine 
production. (A) IFN-γ ELISPOT using CD25− cells at a 10:1 ratio with 
CD25+ (+25+) or CD25− (+25−) cells, PBMCs, or PBMCs depleted of 
CD25+ cells (Depl.) of 28 acute dengue patients. No peptide (wo) or DV-4 
NS3 peptides and inactivated DV-2 were used as a stimulus for 12 h. In 
the presence of CD25+ cells, spot-forming units (SFU)/106 cells are re-
duced (n = 28). (B) Cells of some ELISPOTs were cultured for an additional 
48 h to analyze TNF-α levels in supernatants (n = 5). (C) After culturing 
monocytes of three acute patients at a 1:1 ratio with CD25− (+25−) or 
CD25+ (+25+) cells with DV-4 peptides for 40 h, they were reisolated and 
incubated with antibody-coated inactivated DV-2 for another 48 h. IL-6 
was measured in the supernatants (n = 3). Wo, no dengue antigens 
added. Means and SEM (error bars) are shown.984  REGULATORY T CELLS IN ACUTE DENGUE INFECTION | Lühn et al. 
T reg cells to tissue sites of DV replication in severely ill patients, 
current evidence suggests that the major site of DV replication 
is in the blood. Because the major site of both virus replication 
and disease pathogenesis (caused by plasma leakage) is the vas-
culature, our fi  ndings of an altered balance between T reg cell 
and eff  ector T cell function in the blood of severely ill dengue 
patients are likely to have relevance to disease pathogenesis.
Frequencies of T reg cells have been analyzed in other in-
fectious diseases, but little is known about their numbers and 
function in acute viral infections in man. An expansion has 
been observed in acute mouse herpes simplex virus infection 
(22). With the identifi  cation of FoxP3 and our observation of 
reduced CD4 expression, T reg cells and activated T cells can 
clearly be distinguished, and more information is expected.
For the fi  rst time, we describe in this study the role of T reg 
cells in a nonpersistent viral infection. The balance between reg-
ulatory and eff  ector functions determines the outcome of dis-
ease. In most of the infections examined so far, persistence of the 
pathogen seems to be the price to limit immunopathology (12). 
The DV is cleared quickly within 7 d of illness onset. However, 
the host may pay with substantial immunopathology.
Beside T cells, T reg cells regulate innate immune and B 
cells (Vanitha, D.J., and B.T. Rouse, personal communica-
tion; reference 23). This is particularly interesting in dengue, 
as T reg cells could infl  uence antibody-dependent enhance-
ment and innate immune cell–driven vasoactive cytokine 
  release. Our data suggest a possible infl  uence of T reg cells 
on monocyte activity, but further studies are needed.
In this study, we provide the fi  rst description of T reg 
cells in dengue infection. Although they proliferate in acute 
disease and appear to function normally, we suggest that a 
relatively inadequate expansion is associated with severe den-
gue disease. Therefore, we can add T reg cells to the list of 
factors infl  uencing the outcome of dengue infection. The 
relative contribution of all diff  erent components should be 
further analyzed to shed more light on dengue pathogenesis. 
This will be especially important for the rational design of a 
DV vaccine that can provide eff  ective protection against all 
four serotypes without contributing to immunopathology.
MATERIALS AND METHODS
Study design and patients. 89 serologically confi  rmed (24) dengue pa-
tients were enrolled at The Hospital for Tropical Diseases and grouped based 
on age. Pediatric patients (<15 yr) were further subdivided by severity 
  (Table S1). Patients were admitted on days 1–10 of illness. Blood samples were 
collected on admission, at discharge, and as follow-up samples weeks to sev-
eral months after recovery. As not all time points were available for every 
patient, compared samples are not necessarily matched. Dengue specifi  city of 
T reg cell function was determined using acute samples of an additional 31 
dengue-infected adults. Study protocols were approved by the Scientifi  c and 
Ethical Committee at The Hospital for Tropical Diseases and the Oxford 
Tropical Research Ethical Committee. Written informed consent was ob-
tained from the patients or their legal guardians.
Isolation of cells. Subpopulations of Ficoll-Histopaque–isolated PBMCs 
were sorted with magnetic beads, as no FACS sorter was available in Vietnam. 
CD4+ cells were negatively isolated with a CD4+ T Cell Isolation Kit II 
(Miltenyi Biotec). The purity was 69.08 ± 21.54%. Isolations with low 
  purity were obtained from acute samples and contained erythrocytes. How-
ever, 95.18 ± 2.27% of all nonerythrocyte cells were CD4+. CD25+ cells 
were depleted as well as isolated with Dynabead CD25 (Dynal) and detached 
with Detachabead reagent. Purities of the nonerythrocyte CD25− and 
CD25+ fractions were 92.7 ± 9.48% and 87.9 ± 11.58%, respectively.
Figure 5.  Increased T reg cell frequencies and T reg cell/effector 
T cell ratios in acute dengue infection. Patients were grouped based on 
severity and age (as indicated in I–III). (A) The T reg cell frequencies are 
given as a percentage of the CD25high cells of CD4+ cells. (B) T reg cell/
effector T cell ratios are given. Differences of frequencies and ratios 
between the acute and recovered states are summarized in A (IV) 
and B (IV). Horizontal bars represent mean values.JEM VOL. 204, May 14, 2007  985
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In vitro coculture proliferation assay. 5 × 103 CFSE-labeled CD4+CD25− 
cells were incubated in RPMI/10% human serum with the same amount or 
with 2.5 × 103 CD4+CD25+ or CD4+CD25− cells in anti-CD3–coated 
round-bottom 96-well plates (1 μg/ml OKT3; eBioscience). 3 × 104 
  mitomycin-C–treated allogeneic EBV-immortalized B cells were added to 
each well as APCs. After 5 d, proliferation was analyzed by FACS analysis.
IFN-𝗄 ELISPOT. ELISPOT was performed as described previously (24). 
For activation, a pool of 124 peptides of the DV-4 NS3 protein (15 mers; 
10-mer overlap; 1.5 μM each), 10 μg/ml of inactivated DV-2 (BiosPacifi  c), 
or a pool of irrelevant peptides (Mycobacterium tuberculosis ESAT6) were used. 
Responses higher than four times the background were considered positive. 
Cells and culture media were incubated for another 48 h before analyzing 
TNF-α in the supernatant.
Monocyte coculture assay. CD14+ monocytes were sorted (CD14 beads; 
Miltenyi Biotec). 105 monocytes and 105 CD25− or T reg cells were cul-
tured in 0.2% gelatine-coated round-bottom 96-well plates with or without 
DV-4 NS3 peptide pool. After 40 h, CD14+ cells were sorted again and 
  cultured with or without inactivated DV-2 that was preincubated with auto-
logous plasma to coat virus particles with antibodies. Supernatants were ana-
lyzed for IL-6 after 48 h.
Flow cytometry. 150 μl of blood was incubated ex vivo with combinations 
of four antibodies (BD Biosciences) targeting CD4, 8, 25, 45RO, 62L, 69, 95, 
and CTLA-4. Suitable isotype controls were performed. Intracellular CTLA-4 
was detected in parallel to FoxP3. Cells were analyzed with a fl  ow cytometry 
system (FACSCalibur; BD Biosciences) and FlowJo software (Tree Star).
FoxP3 analysis. FoxP3 analysis was performed by fl  ow cytometry using the 
FoxP3 staining set (clone PCH101; eBioscience).
Cytokine analysis. The levels of secreted IL-10, TNF-α, and IL-6 were 
determined in culture supernatants using a Bio-Plex Cytokine Assay (Bio-
Rad Laboratories).
Statistical analysis. Statistical signifi  cance was calculated with nonpara-
metric unpaired (Mann-Whitney) or paired (ELISPOT and monocyte assays) 
Student’s t tests using Prism 4 software (GraphPad). P-values of <0.05 
were regarded as signifi  cant.
Online supplemental material. Table S1 presents summary characteristics 
of serologically confi  rmed dengue cases. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20061381/DC1.
The authors thank all patients and hospital staff as well as Hoang Truong Long, 
Mike Salmon, Martin Wild, Jerome Feldmann, and Katja Simon for their help.
K. Luhn was supported by the Max Planck Society and the European Molecular 
Biology Organization. C.P. Simmons, E. Moran, B. Willis, and J. Farrar were supported 
by the Wellcome Trust. The study was funded by the Medical Research Council and 
the Wellcome Trust.
The authors have no confl  icting fi  nancial interests.
Submitted: 28 June 2006
Accepted: 21 March 2007
R  E  F  E  R  E  N  C  E  S 
 1. Gubler, D.J. 2002. Epidemic dengue/dengue hemorrhagic fever as a 
public health, social and economic problem in the 21st century. Trends 
Microbiol. 10:100–103.
 2. Halstead, S.B., and E.J. O’Rourke. 1977. Dengue viruses and mono-
nuclear phagocytes. I. Infection enhancement by non-neutralizing anti-
body. J. Exp. Med. 146:201–217.
 3. Halstead, S.B. 1979. In vivo enhancement of dengue virus infec-
tion in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 
140:527–533.
 4. Kurane, I., A.L. Rothman, P.G. Livingston, S. Green, S.J. Gagnon, J. 
Janus, B.L. Innis, S. Nimmannitya, A. Nisalak, and F.A. Ennis. 1994. 
Immunopathologic mechanisms of dengue hemorrhagic fever and den-
gue shock syndrome. Arch. Virol. Suppl. 9:59–64.
 5. Beynon, H.L., D.O. Haskard, K.A. Davies, R. Haroutunian, and M.J. 
Walport. 1993. Combinations of low concentrations of cytokines and 
acute agonists synergize in increasing the permeability of endothelial 
monolayers. Clin. Exp. Immunol. 91:314–319.
 6. Maruo, N., I. Morita, M. Shirao, and S. Murota. 1992. IL-6 increases 
endothelial permeability in vitro. Endocrinology. 131:710–714.
 7. Mongkolsapaya, J., W. Dejnirattisai, X.N. Xu, S. Vasanawathana, N. 
Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, 
T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and 
apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 
9:921–927.
 8. Bashyam, H.S., S. Green, and A.L. Rothman. 2006. Dengue virus-
reactive CD8+ T cells display quantitative and qualitative diff  erences 
in their response to variant epitopes of heterologous viral serotypes. 
J. Immunol. 176:2817–2824.
 9. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for 
  immunologic self-tolerance and negative control of immune responses. 
Annu. Rev. Immunol. 22:531–562.
10. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regula-
tory T cell development by the transcription factor Foxp3. Science. 
299:1057–1061.
11. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T 
cells. Nat. Immunol. 6:338–344.
12.  Belkaid, Y., and B.T. Rouse. 2005. Natural regulatory T cells in infec-
tious disease. Nat. Immunol. 6:353–360.
13. Mills, K.H. 2004. Regulatory T cells: friend or foe in immunity to 
infection? Nat. Rev. Immunol. 4:841–855.
14. Maloy, K.J., L. Salaun, R. Cahill, G. Dougan, N.J. Saunders, and F. 
Powrie. 2003. CD4+CD25+ T(R) cells suppress innate immune 
pathology through cytokine-dependent mechanisms. J. Exp. Med. 
197:111–119.
15. Suvas, S., A.K. Azkur, B.S. Kim, U. Kumaraguru, and B.T. Rouse. 
2004. CD4+CD25+ regulatory T cells control the severity of viral 
  immunoinfl  ammatory lesions. J. Immunol. 172:4123–4132.
16. Apostolou, I., and H. von Boehmer. 2004. In vivo instruction of sup-
pressor commitment in naive T cells. J. Exp. Med. 199:1401–1408.
17. Curotto de Lafaille, M.A., A.C. Lino, N. Kutchukhidze, and J.J. 
Lafaille. 2004. CD25- T cells generate CD25+Foxp3+ regulatory T 
cells by peripheral expansion. J. Immunol. 173:7259–7268.
18. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafl  er. 
2001. CD4+CD25high regulatory cells in human peripheral blood. 
J. Immunol. 167:1245–1253.
19. Taams, L.S., J. Smith, M.H. Rustin, M. Salmon, L.W. Poulter, and 
A.N. Akbar. 2001. Human anergic/suppressive CD4(+)CD25(+) T 
cells: a highly diff  erentiated and apoptosis-prone population. Eur. J. 
Immunol. 31:1122–1131.
20.  Andersson, J., A. Boasso, J. Nilsson, R. Zhang, N.J. Shire, S. Lindback, 
G.M. Shearer, and C.A. Chougnet. 2005. The prevalence of regulatory 
T cells in lymphoid tissue is correlated with viral load in HIV-infected 
patients. J. Immunol. 174:3143–3147.
21. Cabrera, R., Z. Tu, Y. Xu, R.J. Firpi, H.R. Rosen, C. Liu, and D.R. 
Nelson. 2004. An immunomodulatory role for CD4(+)CD25(+) 
regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 
40:1062–1071.
22. Suvas, S., U. Kumaraguru, C.D. Pack, S. Lee, and B.T. Rouse. 2003. 
CD4+CD25+ T cells regulate virus-specifi   c primary and memory 
CD8+ T cell responses. J. Exp. Med. 198:889–901.
23. Taams, L.S., J.M. van Amelsfort, M.M. Tiemessen, K.M. Jacobs, E.C. 
de Jong, A.N. Akbar, J.W. Bijlsma, and F.P. Lafeber. 2005. Modulation 
of monocyte/macrophage function by human CD4+CD25+ regula-
tory T cells. Hum. Immunol. 66:222–230.
24. Simmons, C.P., T. Dong, N.V. Chau, N.T. Dung, T.N. Chau, T.T. 
Thao le, N.T. Dung, T.T. Hien, S. Rowland-Jones, and J. Farrar. 2005. 
Early T-cell responses to dengue virus epitopes in Vietnamese adults 
with secondary dengue virus infections. J. Virol. 79:5665–5675.